In the current study, we found that a nonselective MMP inhibitor, MMP‐2/MMP‐9 inhibitor and MMP‐9 gene deletion consistently attenuated liver fibrosis in the BDL animal model. The gene discussed is MMP9; the disease is Hepatic fibrosis.